Resultado de búsqueda
25 de abr. de 2024 · See Beyond the Lumen. Deliver personalized patient care with the only histologically-validated, objective and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk.
- Elucid Names Scott Huennekens Executive Chairman of The Board
BOSTON, April 25, 2023 – Elucid, Inc., a leading medical...
- Andrew Miller Joins Elucid as Chief Technology Officer
BOSTON, March 28, 2023 – Elucid, Inc., a leading medical...
- Elucid Appoints Windi Hary to Lead Regulatory Affairs and Quality Management
BOSTON, Sept. 6, 2023 – Elucid, Inc., a leading medical...
- Investigator-Initiated Study
Check the publications from Elucid. Latest publications...
- Elucid Names Scott Huennekens Executive Chairman of The Board
Élucid est un média indépendant qui explore l’actualité économique, politique, sociale et environnementale pour en éclairer les mécanismes et les enjeux.
9 de nov. de 2023 · Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies. Press Releases. Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk. BOSTON, Nov. 9, 2023 – Elucid, a leading medical technology company providing physicians with AI ...
28 de mar. de 2023 · Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis. Jun 23, 2022 | Press Releases. Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round.
Elucid | 4,648 followers on LinkedIn. Bringing Imaging to Life | Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a...
9 de nov. de 2023 · Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk. BOSTON, November 09, 2023 -- ( BUSINESS WIRE )-- Elucid, a ...
68K views1 month ago. Cette chaine est une extension du site Élucid (https://www.elucid.media/), un média émancipé du diktat de l’instant présent, qui a pour objectif une diffusio...
